Access cutting-edge glaucoma treatment through this clinical trial at a research site in Glendale. Study-provided care at no cost to qualified participants.
Access glaucoma specialists in Glendale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glaucoma treatment provided free
Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucoma gel stent is when implanted using the ab interno (inside the eye) and ab externo (outside the eye) approach. Adverse events and intraocular pressure will be assessed. XEN63 is an investigational device for the treatment of intraocular pressure (IOP) in patients with glaucoma when both medical and conventional surgical treatments have failed (for
Sponsor: AbbVie
Check if you qualify for this glaucoma clinical trial in Glendale, AZ
If you're searching for glaucoma treatment options in Glendale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Glendale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glaucoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.